维普中文期刊产品整合服务
9篇 您的检索式:作者名="Vander ZEE AG"
    题名 作者 年代 出处 被引量
1Glutathione-S-transferase activity and isoenzyme composition in benign ovarian tumors,untreated malignant ovarian tumors,and malignant ovarian tumors after platinum/cycophsphamide chemotherapy显示文摘Vander ZEE AG Van OMMEN B MEIJER C 1992Br J Cancer1992,66,:1
2Clinical potential of inhibitors of survival pathways and activators of apoptotic pathways in treatment of cervical cancer: changing the apoptotic balance显示文摘Hougardy BM Maduro JH Vander Zee AG 2005Lancet Oncol2005,6,8:1
3Current controver- sies in the management of patients with early stage vulvar cancer 显示文摘Donk MH De Hulln JA Vander zee AG 2010Curr Opin Oncol2010,22,:1
4Sentinel lymph node biopsy in patients with gynecologic cancers Expert panel statement from the International Sentinel Node Society Meeting, February 21, 2008 显示文摘Levenback CF Vander Zee AG Rob L 2009Gynecol Oncol2009,5,:1
5Drug resistance-associated marker Lrp for prediction of response to chemotherapy and prognoses in advanced ovarian carcinoma 显示文摘Izquierdo MA Vander Zee AG Vermorken JB 1995J Natl Cancer Inst1995,87,16:1
6Anticancer drugs aimed at E6 and E7 activity in HPV-positive eervical canc- er显示文摘Tan S de Vries EG vander Zee AG 2012Curr Cancer Drug Targets2012,12,2:1
7Proteasome inhibitor MG132 sensitizes HPV-positive human cervical cancer cells to rhTRAIL-induced apoptosis显示文摘Hougardy BM Maduro JH vander Zee AG 2006Cancer2006,118,8:1
8Drug resistance associated marker LRP for prediction of response to chemotherapy and prognoses in advanced carcinoma 显示文摘Izquierd MA vander Zee AG Vermorken JB 1995J Natl Cancer Inst1995,87,16:1
9Drug resistance-associated marker LRP for prediction of response to chemotherapy and prognosis in advanced ovarian cancer显示文摘Izquierdo MA Vander Zee AG Vermorken JB 1995J Natl Cancer Inst1995,87,16:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费